The MD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The MD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View MD Detailed Price Forecast - CNN Money||View MD Detailed Summary - Google Finance|
|View MD Detailed Summary - Yahoo! Finance||View MD Stock Research & Analysis - Zacks.com|
|View MD Trends & Analysis - Trade-Ideas||View MD Major Holders - Barrons|
|View MD Call Transcripts - NASDAQ||View MD Breaking News & Analysis - Seeking Alpha|
|View MD Annual Report - CompanySpotlight.com||View MD OTC Short Report - OTCShortReport.com|
|View MD Fundamentals - TradeKing||View MD SEC Filings - Bar Chart|
|View Historical Prices for MD - The WSJ||View Performance/Total Return for MD - Morningstar|
|View the Analyst Estimates for MD - MarketWatch||View the Earnings History for MD - CNBC|
|View the MD Earnings - StockMarketWatch||View MD Buy or Sell Recommendations - MacroAxis|
|View the MD Bullish Patterns - American Bulls||View MD Short Pain Metrics - ShortPainBot.com|
|View MD Stock Mentions - StockTwits||View MD Stock Mentions - PennyStockTweets|
|View MD Stock Mentions - Twitter||View MD Investment Forum News - Investor Hub|
|View MD Stock Mentions - Yahoo! Message Board||View MD Stock Mentions - Seeking Alpha|
|View Insider Transactions for MD - SECform4.com||View Insider Transactions for MD - Insider Cow|
|View MD Major Holdings Summary - CNBC||View Insider Disclosure for MD - OTC Markets|
|View Insider Transactions for MD - Yahoo! Finance||View Institutional Holdings for MD - NASDAQ|
|View MD Stock Insight & Charts - FinViz.com||View MD Investment Charts - StockCharts.com|
|View MD Stock Overview & Charts - BarChart||View MD User Generated Charts - Trading View|
Mighty Elliott Associates’ Failed Mednax Inc. (NYSE:MD) Activist Campaign
Posted on Friday September 21, 2018
Paul Singer’s Elliott Associates built a reputation as one of the fiercest activist hedge funds in the investment world. You can easily find an article about this fund by a major media company every week. Paul Singer doesn’t have any problem raising capital whenever he wants to. Yet, we aren’t impressed by its performance at all. […]
3 Top Healthcare Stocks to Buy Right Now
Posted on Tuesday September 18, 2018
A large-cap big pharma, a mid-cap specialized care provider, and a small-cap biotech stand out as great healthcare stocks.
DaVita’s Quarterly Revenue Trend
Posted on Monday September 17, 2018
DaVita (DVA) reported revenues of ~$2.9 billion in the second quarter of 2018, which is a 6.9% YoY (year-over-year) growth compared to $2.7 billion in the second quarter of 2017. DaVita reported 6.9% growth in its top line to $2.89 billion, including an 11.1% growth in revenues from US dialysis and related lab services to $2.57 billion, offset by a 17.7% decrease in revenues for other ancillary services and strategic initiatives in the second quarter of 2018. Medicare and Medicare Advantage revenues were $1.5 billion in the second quarter of 2018, a 16.2% growth compared to $1.3 billion in the second quarter of 2017.
DaVita’s Valuation on September 17
Posted on Monday September 17, 2018
DaVita (DVA) is a biotechnology company focused on the discovery, development, and commercialization of specialist medicines to cater to the medical needs in rare diseases and other specialized conditions. DaVita reported non-GAAP EPS of $1.15 on revenues of $2.9 billion, a 6.9% growth YoY (year-over-year) compared to $2.7 billion in the second quarter of 2017.